coinfect
macaqu
human
metapneumoviru
hmpv
viru
earlier
candid
agent
caus
sar
associ
sever
ill
hmpv
infect
without
sarscov
caus
minor
upper
respiratori
ill
adult
although
hmpv
alon
caus
sever
pneumonia
young
children
van
den
hoogen
et
al
sarscov
deem
necessari
suffici
caus
sar
april
david
heymann
execut
director
communic
diseas
program
klau
albert
osterhau
announc
sar
caus
novel
coronaviru
sarscov
anon
dedic
work
dr
urbani
die
sar
contract
care
patient
vietnam
epidemictimelin
highlight
sar
notori
high
incid
acut
respiratori
distress
respiratori
failur
signific
death
rate
even
healthi
young
adult
tsang
et
al
high
rate
nosocomi
transmiss
superspread
event
sse
shen
et
al
lloydsmith
et
al
galvani
may
fig
epidem
china
almost
becam
pandem
physician
guest
hotel
metropol
hong
kong
infect
treat
sar
patient
guangzhou
unknowingli
four
case
report
guangzhou
citi
dec
link
laboratori
introduc
sarscov
hong
kong
februari
probabl
superspread
hong
kong
becam
ground
zero
howev
place
sarscov
spread
chain
transmiss
stop
promptli
isol
patient
accord
basic
reproduct
number
r
arriv
averag
number
infect
produc
infect
individu
suscept
popul
sar
contagi
influenza
r
riley
et
al
respect
howev
simplif
ignor
properti
certain
infecti
diseas
includ
smallpox
influenza
sar
call
heterogen
individu
infecti
highli
variabl
infecti
mean
infect
individu
may
caus
explos
transmiss
give
rise
ss
sar
epidem
spectrum
infecti
seen
includ
ss
unev
termin
transmiss
chain
explos
outbreak
galvani
may
lloydsmith
et
al
ss
like
requir
high
level
viral
shed
other
factor
togeth
determin
individu
reproduct
number
lloydsmith
et
al
one
factor
might
product
larg
amount
bioaerosol
certain
individu
edward
et
al
reduc
bioaerosol
inhal
nebul
salin
edward
et
al
andor
use
cough
suppress
could
impact
individu
reproduct
number
reduc
occurr
ss
anoth
cofactor
might
pneumon
phase
airborn
dissemin
viru
lloydsmith
et
al
infecti
diseas
agent
exist
quanta
plasma
airborn
dissemin
difficult
prove
owe
stochast
process
involv
distribut
virus
aerosol
toronto
portion
sar
epidem
investig
use
stateoftheart
air
sampl
devic
confirm
presenc
sarscov
air
patient
room
booth
et
al
studi
togeth
data
investig
transmiss
aircraft
huge
outbreak
sar
amoy
garden
hong
kong
show
sarscov
opportunist
airborn
pathogen
roy
milton
recogn
airborn
dissemin
sarscov
rout
transmiss
facil
upgrad
impact
airborn
infecti
diseas
well
high
incid
nosocomi
transmiss
sarscov
epidem
expos
weak
infect
control
procedur
locat
medic
worker
becam
vector
sarscov
meng
et
al
occur
everywher
seto
et
al
multipl
layer
defens
need
chowel
et
al
suggest
use
model
r
r
distribut
lie
r
even
perfect
isol
chowel
et
al
help
measur
might
includ
avoid
crowd
clinic
ward
wear
face
mask
seto
et
al
avoid
aerosol
procedur
possibl
tong
improv
ventil
design
rate
liao
et
al
make
sure
weak
link
infect
control
theori
sarscov
came
anim
reservoir
gain
credenc
field
investig
show
signific
number
earli
patient
foodhandl
anon
normil
enserink
xu
et
al
yi
guan
other
investig
food
market
guangdong
varieti
small
anim
kept
unhygien
heapedup
cage
prior
sale
sarscovlik
coronavirus
promptli
identifi
sever
himalayan
palm
civet
paguma
larvata
one
raccoon
dog
nyctereut
procyonoid
antibodi
sarscov
also
found
market
worker
relationship
isol
anim
isol
human
appear
result
oneway
transmiss
anim
human
delet
found
strain
sarscov
isol
human
compar
civet
sarscov
easier
lose
nucleotid
gain
chines
kan
et
al
song
et
al
genom
comparison
suggest
sarscov
unlik
recombin
human
anim
coronavirus
variou
anim
coronavirus
rule
natur
laboratori
chimer
holm
rambaut
thu
sarscov
probabl
zoonot
viru
holm
zhong
et
al
also
found
civet
make
good
amplif
reservoir
sarscov
genom
rna
persist
spleen
lymph
node
civet
long
day
divers
sarscov
genom
among
human
isol
greatest
guangdong
agre
anim
studi
suggest
south
china
site
emerg
viru
guan
et
al
moreov
human
like
occur
person
recent
southern
chines
ancestri
indigen
taiwanes
distant
hla
class
gene
shown
significantli
less
suscept
sar
resid
taiwan
immigr
mainland
china
lin
et
al
believ
human
sarscov
occur
week
epidem
sar
china
estim
date
interspeci
leap
base
mutat
analys
singapor
china
remark
close
agreement
late
octob
midnovemb
respect
chines
vega
et
al
estim
mutat
rate
nucleotid
per
site
per
day
singapor
isol
china
isol
remark
agreement
rate
taiwan
isol
rate
mutat
among
slowest
rna
virus
retrospect
seroepidemiolog
studi
confirm
sarscov
begin
circul
human
recent
sera
collect
hong
kong
may
zheng
et
al
none
sera
collect
guangdong
earli
zhong
et
al
minim
reactiv
elisa
sera
us
blood
donor
contain
antibodi
sarscov
zheng
et
al
quantifi
titer
antibodi
earli
sera
higher
civet
sarscov
human
isol
sarscov
zheng
et
al
howev
farm
civet
elsewher
china
mostli
neg
sarscov
tu
et
al
hunt
natur
reservoir
continu
take
clue
zoonot
scientist
turn
bat
possibl
anim
reservoir
sinc
bat
shown
reservoir
rabi
viru
ebola
viru
hendra
viru
menangl
viru
nipah
viru
dobson
leroy
et
al
two
independ
group
publish
definit
find
bat
natur
reservoir
sarscov
kwokyung
yuen
discov
three
novel
coronavirus
differ
speci
bat
includ
one
viru
nucleotid
ident
sarscov
viru
name
batsarscov
poon
et
al
batsarscov
found
insectivor
chines
horsesho
bat
rhinolophu
sinicu
nearli
ident
civet
sarscov
includ
preserv
segment
found
major
human
isol
sarscov
also
nearli
ident
civet
sarscov
slcov
perhap
relat
strain
found
rhinolophu
pearsoni
li
et
al
shi
zhang
wang
sinoaustralian
cooper
effort
also
involv
hong
kong
univers
produc
proof
bat
natur
reservoir
sarscovlik
coronavirus
find
lead
vaccin
drug
treatment
sar
dobson
sarscov
appear
jump
speci
easili
wildlif
reservoir
sarscov
may
discov
macaqu
domest
cat
ferret
raccoon
dog
pig
even
mice
known
suscept
sarscov
infect
martina
et
al
wentworth
et
al
chen
et
al
li
et
al
nevertheless
fact
bat
roost
larg
coloni
make
ideal
reservoir
maintain
virus
microorgan
normil
addit
bat
mammalia
class
human
virus
bat
requir
great
chang
infect
human
cell
li
et
al
epidem
declar
four
small
subsequ
outbreak
occur
three
result
sarscov
escap
laboratori
infect
personnel
david
ho
predict
might
occur
enserink
occur
russian
influenza
horimoto
kawaoka
fourth
case
form
frust
reemerg
epicent
origin
outbreak
guangzhou
decemb
januari
enserink
liang
et
al
normil
song
et
al
reemerg
four
peopl
develop
sar
confirm
sarscov
rtpcr
three
direct
indirect
contact
palm
civet
one
live
near
hospit
earlier
admit
mani
patient
sar
recov
seroconvert
amplifi
sequenc
virus
isol
similar
sarscov
found
preced
winter
cage
anim
chines
song
et
al
one
patient
reemerg
outbreak
contact
civet
earlier
dispos
dead
rat
lead
health
offici
guangdong
trap
rodent
near
resid
rat
rattu
rattu
found
sarscov
fece
lung
tissu
http
though
overtli
ill
taxonomi
phylogeni
sarscov
belong
famili
coronavirida
envelop
rna
virus
order
nidoviral
cavanagh
coronavirus
classifi
three
serogroup
virus
group
mammalian
virus
group
contain
avian
virus
human
coronavirus
hcov
found
group
group
respons
gener
mild
upper
respiratori
tract
ill
posit
sarscov
snijder
et
al
use
root
phylogenet
tree
includ
outgroup
equin
toroviru
etov
conclud
sarscov
distantli
relat
establish
group
coronavirus
agre
peiri
phylogenet
analysi
use
polymeras
gene
genom
sarscov
close
relat
group
coronavirus
magiorkini
et
al
sarscov
place
new
subgroup
group
coronavirus
assign
new
subgroup
stadler
et
al
gorbalenya
et
al
addit
batsarscov
assign
recent
subgroup
sarscov
characterist
morpholog
coronavirus
spike
protein
peplom
clubshap
project
surfac
give
envelop
viral
particl
crownlik
henc
corona
latin
crown
appear
electron
microscop
fig
atom
forc
microscopi
reveal
virion
least
spheric
spike
diamet
nm
lin
et
al
center
appear
amorph
coronavirus
largest
known
nonseg
genom
among
rna
virus
kb
genom
mimic
eukaryot
mrna
singlestrand
positivesens
rna
cap
methyl
end
polyadenyl
end
consequ
stabl
prokaryot
mrna
optim
translat
eukaryot
translat
machineri
ie
optim
infect
polymeras
includ
particl
entir
genom
sequenc
sarscov
work
month
leung
marra
et
al
rota
et
al
sarscov
genom
fig
begin
end
untransl
region
utr
span
nucleotid
respect
sabin
strain
polioviru
mutat
utr
respons
attenu
permit
vaccin
product
gutierrez
et
al
sarscov
genom
predict
open
read
frame
orf
encod
protein
marra
et
al
rota
et
al
snijder
et
al
certain
strain
lack
one
orf
chines
wherea
other
orf
groneberg
et
al
altern
nomenclatur
relat
viru
chapter
enclos
within
bracket
sar
chip
offer
free
research
begin
june
nation
institut
allergi
infecti
diseas
nih
usa
base
success
derisi
viral
discoveri
microarray
microarray
gene
express
studi
peripher
blood
shown
discrimin
accur
sar
patient
nonsar
control
lee
et
al
shanghai
proteom
sarscov
vero
cell
analyz
use
convent
proteom
tool
twodimension
liquid
chromatographi
electrospray
ioniz
tandem
mass
spectrometri
lcesimsm
addit
isotopelabel
affin
tag
technolog
coupl
twodimension
lcmsm
use
identifi
quantifi
differenti
express
protein
infect
vs
noninfect
vero
cell
beij
kang
et
al
develop
mass
spectrometri
decis
tree
classif
algorithm
use
surfaceenhanc
laser
desorptionion
timeofflight
mass
spectrometri
selditof
ms
protein
array
predict
virolog
diagnosi
base
sever
serum
proteom
marker
kang
et
al
use
similar
technolog
poon
et
al
chines
univers
hong
kong
cuhk
perform
serial
analys
plasma
proteom
signatur
pediatr
patient
sar
show
potenti
predict
clinic
outcom
base
correl
viral
load
togeth
span
twothird
viral
genom
locat
end
encod
replicas
polyprotein
pp
express
immedi
infect
translat
product
detect
cell
cultur
earli
h
infect
prentic
et
al
like
coronavirus
mani
virus
strategi
use
translat
requir
slipperi
sequenc
structur
mrna
element
known
pseudoknot
caus
frameshift
termin
codon
slipperi
sequenc
highli
conserv
would
function
mutat
anoth
ci
element
discov
attenu
slipperi
sequenc
downregul
frameshift
effici
transcript
attenu
thought
enabl
sarscov
synthes
fulllength
subgenomiclength
antisens
rna
intermedi
sixteen
nonstructur
protein
nsp
deriv
proteolyt
cleavag
two
rather
three
viral
proteinas
see
recent
predict
nsp
identifi
immunoblot
subcellular
local
studi
immunofluoresc
confoc
microscopi
prentic
et
al
predict
confirm
along
immunolog
relat
product
differ
size
await
character
prentic
et
al
essenti
viral
replic
vero
cell
graham
et
al
defect
interferon
ifn
product
emeni
morgan
two
viral
proteas
specif
papainlik
cystein
proteinas
sarscov
main
chymotrypsinlik
proteas
also
known
cystein
proteinas
substrat
specif
conserv
among
coronavirus
necessari
coand
posttransl
process
polyprotein
cleav
elong
polypeptid
cotransl
wherea
respons
cleavag
site
xdomain
homolog
adenosin
diphosphateribos
phosphatas
adrp
involv
pretrna
splice
phosphatas
activ
recent
demonstr
vitro
assay
saikatendu
et
al
hydrophob
protein
kda
sdspolyacrylamid
gel
predict
mass
kda
similar
murin
hepat
viru
mhv
prentic
et
al
use
artifici
neural
network
spaan
bioinformat
softwar
track
record
discov
adhesin
led
find
adhesinlik
characterist
function
also
ascrib
spike
sachdeva
et
al
assembl
cylindr
hexadecam
inner
posit
charg
intern
diamet
thought
confer
process
rnadepend
rna
polymeras
rdrp
zhai
et
al
scientist
clone
express
e
coli
crystal
gener
crystallograph
data
effort
facilit
drug
design
campanacci
et
al
show
singlestrand
rnabind
protein
display
oligosaccharideoligonucleotid
fold
uniqu
world
rna
virus
egloff
et
al
function
sarscov
rnadepend
rna
polymeras
rdrp
pol
promiscu
helicas
unwind
rna
dna
atpas
activ
belong
helicas
superfamili
ntermin
domain
may
play
role
stabil
sarscov
genom
ntermin
domain
nsp
homolog
exonulceas
exon
specul
may
perform
function
rna
proofread
repair
andor
recombin
sarscov
genom
protect
capabl
may
explain
slow
estim
mutat
rate
chines
vega
et
al
yeh
et
al
sequenc
ident
laboratoryacquir
case
stabl
laboratori
isol
vega
et
al
observ
unexpect
resist
ribavirin
drug
predispos
rna
virus
go
error
catastroph
eigen
crotti
et
al
parient
et
al
nevertheless
preliminari
observ
suggest
quasispeci
occur
sarscov
rna
virus
although
patient
studi
quasispeci
exist
receiv
ribavirin
xu
et
al
b
confound
factor
experi
ctermin
part
homolog
poli
u
specif
endoribonucleas
xendou
involv
small
nucleolar
rna
process
util
confirm
specif
cleavag
uridyl
residu
structur
analysi
show
arrang
dimer
trimer
possibl
rnabind
site
guarino
et
al
show
homolog
omethyltransferas
omt
von
grotthuss
et
al
could
possibl
use
cap
viral
mrna
disguis
eukaryot
mrna
cap
recogn
eukaryot
initi
factor
togeth
initi
factor
recruit
ribosom
subunit
initi
complex
scan
mrna
initi
codon
aug
whereupon
ribosom
subunit
dock
begin
peptid
elong
coloc
studi
show
enzym
assembl
one
vesicl
membraneassoci
replic
unit
prentic
et
al
usurp
cellular
process
viral
replic
without
dna
phase
mrna
transcript
coronavirus
includ
sarscov
virus
order
nidoviral
produc
set
cotermin
mrna
host
cell
lai
cavanagh
sarscov
orf
downstream
replicas
translat
nest
set
eight
subgenom
mrna
identifi
experiment
infect
cell
thiel
et
al
also
like
coronavirus
subgenom
mrna
linedup
genom
cotermin
end
viru
end
also
ident
minim
consensu
sequenc
end
suffici
direct
synthesi
subgenom
mrna
sequenc
embed
stretch
nucleotid
upstream
orf
subgenom
mrna
result
fusion
nucleotid
genom
leader
transcript
regulatori
sequenc
tr
uniqu
bodi
tr
preced
orf
join
two
region
probabl
achiev
discontinu
step
minusstrand
synthesi
stadler
et
al
thiel
et
al
trss
regul
viral
transcript
translat
encod
class
viral
membranefus
protein
acid
transmembran
protein
precursor
pro
glycosyl
golgi
apparatu
proteolyt
process
furin
host
membranebound
proprotein
convertas
shown
scientist
clinic
research
institut
montreal
extracellular
domain
contain
receptorbind
entrymedi
region
breach
cell
membran
barrier
singl
import
step
infect
girogl
et
al
li
et
al
neutral
antibodi
especi
receptorbind
region
prevent
infect
et
al
c
bind
host
cell
membran
protein
angiotensin
convert
enzym
dimitrov
li
et
al
kuba
et
al
newli
discov
also
employ
receptor
civet
differ
human
human
isol
sarscov
fulli
adapt
shown
increas
bind
infect
introduct
residu
human
receptor
li
et
al
expect
solubl
solubl
ace
sace
block
bind
vero
cell
hofmann
et
al
howev
mutat
catalyt
site
effect
sinduc
syncytia
format
suggest
exist
ace
inhibitor
block
sarscov
infect
dimitrov
receptorbind
region
local
amino
acid
residu
region
neighborhood
breslin
et
al
avid
bind
li
et
al
viral
entri
yi
et
al
immunogen
yi
et
al
affect
singl
amino
acid
substitut
within
region
demonstr
resolut
holm
li
et
al
bind
way
conform
electrostat
interact
yi
et
al
strength
differ
depend
viral
strain
civet
bind
avidli
poorli
although
human
isol
sarscov
bind
strongli
li
et
al
two
region
sproteinbind
site
two
residu
receptorbind
region
larg
determin
differ
human
isol
sarscov
small
neutral
residu
asparagin
posit
replac
basic
residu
civet
better
accommod
lysin
posit
posit
serin
civet
replac
threonin
extra
methyl
group
human
isol
residu
absolut
conserv
evalu
isol
epidem
li
et
al
find
suggest
adapt
critic
viral
adapt
human
ruan
et
al
bind
undergo
conform
chang
mediat
region
tripet
et
al
xu
et
al
presum
expos
cleavag
site
follow
phdepend
host
endosom
cathepsin
lmediat
proteolysi
simmon
et
al
extracellular
proteas
excret
neutrophil
facilit
pathway
signific
degre
proteas
also
enabl
entri
cell
sarscov
adsorb
cell
surfac
matsuyama
et
al
similar
way
ebola
viru
hendra
viru
also
util
cathepsin
l
endocyt
pathway
cell
entri
chandran
et
al
pager
dutch
final
step
membran
fusion
viral
entri
depend
format
sixhelix
bundl
heptad
repeat
region
also
predict
other
use
insilico
techniqu
kliger
levanon
oligomer
requir
form
sixhelix
bundl
structur
similar
fusogen
core
put
fusion
peptid
locat
region
immedi
upstream
bosch
et
al
provid
detail
model
fusion
core
supekar
et
al
xu
et
al
guillen
et
al
last
step
viral
entri
appear
suscept
inhibit
compon
innat
immun
mannosebind
lectin
mbl
leikina
et
al
sever
cellular
protein
also
util
facilit
entri
cell
includ
hivattach
factor
dendrit
cellspecif
intercellular
adhes
moleculegrab
nonintegrin
dcsign
ctype
lectin
express
dendrit
cell
lsign
dcsignr
jeffer
et
al
marzi
et
al
way
sarscov
join
hiv
dengu
viru
cmv
exploit
dendrit
cell
vehicl
cellmedi
dissemin
anoth
lectin
lsectin
recent
shown
bind
could
assist
viral
entri
liver
lymph
node
express
sinusoid
endotheli
cell
gramberg
et
al
short
period
time
sarscov
evolv
one
ineffici
enter
human
cell
civet
strain
one
acquir
key
front
back
door
less
remark
influenza
viru
strain
acquir
abil
effici
enter
human
cell
mutat
hemagglutinin
cleavag
site
becam
promiscu
cleav
wide
rang
host
proteas
horimoto
kawaoka
structur
protein
encod
small
envelop
e
protein
amino
acid
bind
inactiv
antiapoptot
protein
bclxl
caus
vitro
vivo
lymphocytotox
e
protein
detect
cultur
supernat
could
conceiv
taken
vivo
lymphocyt
infect
viru
encod
membran
protein
abund
viral
glycoprotein
amino
acid
transmembran
protein
short
ntermin
ectoand
long
ctermin
interior
domain
acid
domain
shown
interact
nucleocapsid
trigger
viral
encapsid
fang
et
al
encod
nucleocapsid
n
protein
amino
acid
basic
protein
bind
viral
rna
via
nand
ctermin
region
hsieh
et
al
spontan
assembl
viruslik
particl
vlp
solut
azizi
et
al
role
apoptosi
postul
surjit
et
al
function
accessori
protein
still
unknown
cai
et
al
systemat
delet
groupspecif
orf
alon
combin
significantli
impair
viral
viabil
cell
cultur
mice
possibl
involv
struggl
viru
natur
host
bat
delet
groupspecif
orf
coronavirus
often
lead
attenu
vivo
evid
emerg
delet
might
pathogen
man
encod
respect
two
novel
protein
found
coronavirus
tan
et
al
yu
et
al
ito
et
al
implic
trigger
apoptosi
yuan
et
al
coloc
packag
virion
ito
et
al
encod
also
local
rough
endoplasm
reticulumgolgi
compart
report
induc
apoptosi
caspasedepend
mechan
tan
et
al
tempt
associ
apoptosisinduc
activ
lymphopenia
trojan
hors
role
infect
lymphocyt
sarscov
might
need
surviv
gu
et
al
caus
lymphocyt
apoptosi
viru
delet
might
permit
surviv
viru
cell
would
otherwis
destroy
lymphocyt
assembl
viral
particl
trigger
associ
membranebound
protein
n
protein
coat
helic
viral
nucleocapsid
viral
packag
depend
viral
rnabind
motif
nand
ctermin
n
packag
signal
hypervari
region
near
terminu
similar
found
mhv
bcov
chang
et
al
hsieh
et
al
virion
assembl
bud
vesicl
form
compart
endoplasm
reticulum
golgi
apparatu
pick
carbohydr
moieti
releas
exocytosi
entir
process
sarscov
replic
take
h
yount
et
al
prentic
et
al
compar
h
influenza
viru
reflect
slow
rise
viral
titer
sar
patient
peiri
et
al
tsang
et
al
cheng
et
al
microarray
studi
host
gene
express
shown
sarscov
elicit
nonspecif
innat
inflammatori
reaction
rather
antivir
respons
reghunathan
et
al
sarscov
sens
edit
respons
dendrit
cell
macrophag
result
induct
nonspecif
inflammatori
chemokin
lowlevel
proinflammatori
cytokin
product
mute
antivir
cytokin
respons
includ
ifn
data
suggest
fact
sarscov
avoid
activ
dendrit
cell
macrophag
ziegler
et
al
suppress
respons
would
otherwis
orchestr
humor
immun
respons
could
also
result
search
explan
absent
ifnb
respons
found
sarscov
block
step
earli
nuclear
transport
key
ifnb
gene
transcript
factor
spiegel
et
al
anoth
cellular
signal
pathway
affect
activ
n
chang
et
al
n
protein
activ
nuclear
factor
nf
kb
vero
cell
vero
cell
hela
cell
lung
epitheli
fibroblast
cell
line
liao
et
al
virus
activ
nfkb
includ
human
tcell
lymphotrop
viru
type
herp
virus
hepat
c
viru
hepat
b
viru
influenza
virus
among
other
santoro
et
al
protean
role
nfkb
inflamm
cell
prolifer
cell
surviv
apoptosi
central
regul
innat
adapt
immun
respons
make
ideal
intracellular
target
viru
import
aspect
sarscov
evas
immun
respons
occur
abrog
intracellular
antivir
respons
aptli
describ
intracellular
warfar
krug
et
al
also
occur
viral
infect
samuel
webbi
et
al
vero
cell
stabli
express
mxa
samuel
broadspectrum
antirna
viru
larg
gtpase
protein
induc
ifn
b
g
continu
produc
viru
suggest
sarscov
countermeasur
import
defens
mechan
spiegel
et
al
adapt
immun
system
viral
target
direct
viral
infect
lymphocyt
gu
et
al
induct
lymphocyt
apoptosi
chen
et
al
multipl
toxic
viral
molecul
caus
apoptosi
name
e
protein
yuan
et
al
tan
et
al
har
power
comput
biolog
scientist
beij
genom
institut
investig
viral
virul
evas
strategi
compar
sarscov
protein
motif
known
human
protein
viral
protein
toxic
motif
found
local
variou
sarscov
protein
potenti
relev
therapi
vaccin
design
exampl
superantigenlik
motif
e
n
accessori
protein
thought
caus
lymphocyt
apoptosi
activ
absenc
appropri
costimulatori
signal
enterotoxin
motif
could
account
diarrhea
seen
mani
sar
victim
viral
countermeasur
may
identifi
futur
perhap
includ
antirna
interfer
rnai
progress
made
applic
rnaibas
therapeut
sarscov
wang
et
al
li
et
al
shi
et
al
tao
et
al
wu
et
al
particular
recent
advanc
deliveri
sirna
hope
specif
target
scatter
rel
inaccess
lymphocyt
dendrit
cell
amelior
assault
immun
system
sarscov
comparison
genom
sarscov
sarscovlik
anim
coronavirus
palm
civet
raccoon
dog
reveal
human
isol
sarscov
share
delet
seen
civet
sarscov
addit
polymorph
also
identifi
show
human
sarscov
evolv
civet
sarscov
initi
effort
also
catalog
import
genom
data
comparison
newli
discov
sarscovlik
virus
batsarscov
slcov
li
et
al
batsarscov
contain
sequenc
delet
human
sarscov
reveal
even
closer
kinship
civet
sarscov
chines
sar
molecular
epidemiolog
consortium
collect
spatial
tempor
divers
specimen
human
anim
studi
sarscov
evolut
chines
sever
major
sarscov
genotyp
singlenucleotid
variat
snv
discov
among
sequenc
studi
certain
snv
exampl
second
third
nucleotid
codon
creat
socal
multipl
substitut
codon
chanc
occurr
zero
point
toward
develop
natur
select
anoth
observ
phenomenon
gc
enrich
thought
metabol
expens
intracellular
pathogen
rocha
danchin
also
could
due
pressur
host
sabotag
akin
gt
edit
host
famili
protein
suggest
adapt
pressur
rather
random
mutat
genotyp
base
snv
loci
defin
civet
sarscov
gacgc
earli
gactc
motif
human
isol
sarscov
ggctc
gattc
motif
middl
epidem
late
tgttt
motif
correspond
nonsynonym
chang
noncod
region
liu
similar
chang
occur
evolut
three
significantli
variabl
protein
viru
adapt
human
kan
et
al
song
et
al
sequenc
delet
observ
domin
human
strain
includ
entir
orf
specifi
groupspecif
accessori
protein
delet
civet
sarscov
creat
uncommon
strain
limit
rang
isol
earli
epidem
delet
similar
anim
sarscov
isol
farm
civet
hubei
provinc
china
chines
yet
anoth
strain
isol
late
epidem
hong
kong
may
lack
sequenc
correspond
entir
data
indic
rapid
viral
genom
adjust
human
host
earli
epidem
particularli
specif
mutat
hotspot
receptorbind
region
slow
middl
epidem
late
chang
produc
strong
purifi
select
chines
yeh
et
al
kan
et
al
investig
also
reveal
critic
viral
adapt
human
went
evolutionari
path
beij
earlier
guangzhou
switch
ggctc
tgttt
motif
patient
belong
cluster
liu
molecular
event
occur
late
earli
outbreak
guangzhou
kan
et
al
song
et
al
throughout
period
civet
sarscov
evolv
adapt
civet
cat
produc
higher
viral
load
confirm
civet
normal
reservoir
howev
given
opportun
appear
sarscov
could
establish
reservoir
farm
civet
find
elucid
adapt
sharpen
percept
molecular
emerg
human
isol
sarscov
much
virul
contagi
anim
strain
import
public
health
offici
quickli
find
strain
deal
event
outbreak
genotyp
sarscov
acquir
public
health
signific
scientist
chines
univers
hong
kong
develop
allel
discrimin
genotyp
assay
use
nucleas
probe
valid
discrimin
human
anim
strain
sarscov
comparison
direct
sequenc
chung
et
al
thought
sarscov
spread
person
person
mucos
surfac
virusladen
bodi
fluid
primarili
respiratori
secret
anon
tear
loon
et
al
tong
lai
sweat
also
found
contain
sarscov
rna
although
role
diseas
transmiss
unknown
cough
mean
airborn
dissemin
difficult
prove
seto
et
al
tong
demonstr
experiment
booth
et
al
larg
droplet
emit
cough
sneez
project
rang
believ
contribut
airborn
transmiss
fowler
et
al
yu
et
al
yu
et
al
booth
et
al
li
et
al
g
tong
possibl
superspread
edward
et
al
inadvert
aerosol
infect
bodi
materi
fece
also
thought
possibl
mean
transmiss
yu
sung
yu
et
al
fecaltoor
transmiss
document
although
viral
nucleic
acid
found
sewag
nuclei
acid
test
rtpcr
institut
theoret
could
prevent
transfusionassoci
transmiss
futur
epidem
sarscov
shown
present
blood
asymptomat
person
schmidt
et
al
clinic
cours
divid
three
phase
peiri
et
al
phase
correl
upper
respiratori
viral
replic
viremia
phase
correl
lower
respiratori
tract
viral
replic
phase
character
function
critic
pulmonari
injuri
due
either
viru
alon
mazzulli
et
al
conjunct
immunolog
damag
matsuyama
et
al
incub
period
sar
rang
day
exposur
mean
day
occasion
long
day
lee
et
al
tsang
et
al
prodrom
consist
flulik
symptom
malais
myalgia
headach
fever
rigor
cough
initi
symptom
present
greater
half
patient
coryza
sore
throat
present
minor
case
day
rang
day
patient
develop
exert
dyspnea
chest
xray
reveal
opac
lung
almost
patient
consist
alveolar
interstiti
exud
zhong
et
al
phase
last
week
wateri
diarrhea
develop
patient
admit
princess
margaret
hospit
hong
kong
kwan
et
al
higher
incid
diarrhea
found
cohort
patient
amoy
garden
correl
higher
viral
load
stool
patient
requir
intens
care
requir
ventilatori
support
asymptomat
case
extrem
rare
epidem
lai
et
al
rule
earli
phase
epidem
china
sarscov
adapt
human
host
lee
et
al
elderli
patient
febril
christian
et
al
case
incub
period
convalesc
protract
patient
princ
wale
hospit
present
diarrhea
fever
without
respiratori
symptom
children
also
infect
although
symptom
clinic
cours
typic
mild
leung
et
al
kwan
et
al
pregnanc
alter
cours
sar
mother
perinat
infect
report
shek
et
al
children
also
present
sole
diarrhea
kwan
et
al
recoveri
occur
begin
day
diseas
onset
christian
et
al
convalesc
patient
longer
excret
viru
stool
patient
appar
recoveri
follow
exacerb
peiri
et
al
arteri
oxygen
desatur
variabl
degre
respiratori
impair
failur
one
year
postinfect
onethird
patient
continu
pulmonari
function
impair
ong
et
al
osteonecrosi
occur
signific
proport
patient
receiv
system
steroid
children
also
experi
complic
griffith
et
al
lymphopenia
thrombocytopenia
commonli
present
choi
et
al
decreas
tlymphocyt
occur
earli
advers
affect
prognosi
serum
chemistri
often
reveal
elev
lactat
dehydrogenas
ldh
aminotransferas
level
creatin
phosphokinas
level
ldh
independ
predictor
mortal
choi
et
al
initi
elev
creactiv
protein
level
report
correl
poor
outcom
human
express
lung
intestin
test
kidney
endothelium
heart
larg
part
determin
tissu
tropism
donoghu
et
al
tipni
et
al
harmer
et
al
leung
et
al
ham
et
al
respiratori
epithelium
express
differenti
cell
particular
ciliat
cell
impli
bronchioalveolar
stem
cell
kim
et
al
poorli
infect
abund
evid
point
viral
infect
pneumocyt
mechan
lung
injuri
nichol
et
al
et
al
shieh
et
al
howev
induct
immun
respons
viral
protein
also
implic
pathogenesi
exampl
ntermin
ctermin
activ
mapk
independ
nfkb
lung
epitheli
cell
monocyt
fibroblast
vitro
lead
induct
consist
observ
level
elev
patient
sar
turn
recruit
neutrophil
lung
therebi
facilit
sarscov
entri
pneumocyt
elabor
proteas
wong
et
al
matsuyama
et
al
tang
et
al
host
factor
appear
also
contribut
diffus
alveolar
damag
peptid
hormon
angiotensin
ii
posit
neg
regul
ace
product
gene
respect
shown
particip
spikeinduc
diffus
alveolar
damag
mice
kuba
et
al
nichol
peiri
explain
sar
patient
carri
allel
delet
involv
intron
polymorph
gene
associ
higher
level
sace
prone
hypoxemia
itoyama
et
al
allel
increas
sace
result
higher
angiotensin
ii
level
henc
suscept
injuri
sarscov
protect
inactiv
angiotensin
ii
nichol
peiri
interrupt
reninangiotensin
system
protect
mice
exacerb
lung
injuri
aggrav
inject
studi
show
viral
protein
tip
balanc
normal
physiolog
caus
diseas
therapeut
implic
acut
respiratori
distress
syndrom
ard
beyond
respiratori
damag
caus
sarscov
note
explan
need
gener
mild
infect
also
util
nichol
peiri
perhap
similar
limit
human
murin
pathophysiolog
infect
viral
host
factor
account
case
show
appar
improv
follow
later
deterior
peiri
et
al
one
school
thought
incrimin
innat
immun
system
peiri
et
al
investig
alveolar
macrophag
sentinel
lower
respiratori
tract
found
cultur
macrophag
infect
evidenc
translat
n
protein
support
sarscov
replic
addit
wherea
macrophag
infect
influenza
produc
ifnb
evid
induct
ifnb
sarscovinfect
macrophag
instead
elabor
chemokin
protein
chemotact
protein
possibl
explain
aspect
pathogenesi
autoimmun
explan
akin
influenza
virusinduc
goodpastur
syndrom
dengu
hemorrhag
fever
dengu
shock
syndrom
suggest
antibodi
discov
convalesc
sera
crossreact
lung
epitheli
cell
antibodi
report
cytotox
pneumocyt
found
nonsar
pneumonia
patient
translat
therapeut
term
studi
suggest
steroid
plasmapheresi
might
tri
correct
pathogenet
mechan
histolog
lung
evid
patchi
diffus
alveolar
damag
mix
inflammatori
infiltr
edema
microthrombi
lang
et
al
hyalin
membran
format
ding
et
al
frank
et
al
ksiazek
et
al
nichol
et
al
sarscov
identifi
within
fibrin
macrophag
pneumocyt
immunohistochemistri
situ
hybrid
electron
microscopi
nichol
et
al
shieh
et
al
desquam
pneumocyt
prolifer
pneumocyt
consist
present
frank
et
al
griffith
et
al
multinucl
pneumocyt
macrophag
similar
observ
cell
cultur
sometim
found
frank
et
al
sarscovinfect
cell
display
surfac
fuse
adjac
cell
express
petit
et
al
result
littleappreci
rout
adjac
cell
appear
becom
infect
accret
even
releas
matur
progeni
viru
nuclei
may
enlarg
nucleoli
promin
intranuclear
inclus
observ
consist
fact
sarscov
replic
cytoplasm
heal
begin
accompani
squamou
metaplasia
frank
et
al
fibrosi
patient
pneumomediastinum
report
patient
unrel
intub
posit
pressur
ventil
peiri
et
al
chu
et
al
although
enter
infect
sarscov
common
sar
patient
viral
replic
gi
tract
document
morpholog
chang
minim
patient
lymphopenia
lymphoid
deplet
observ
splenic
white
pulp
mucosaassoci
lymphoid
tissu
gi
tract
ding
et
al
zhong
et
al
tse
et
al
gu
et
al
strike
hepat
mitot
activ
report
two
patient
proof
sarscov
infect
liver
howev
remain
elus
evid
system
vascul
report
patient
die
chines
hospit
ding
et
al
recent
immunemedi
orchiti
describ
men
die
sar
unlik
mump
orchiti
usual
alway
unilater
involv
bilater
appear
target
germ
cell
possibl
reduc
fertil
men
recov
infect
innat
immun
respons
sarscov
infect
includ
elabor
acutephas
protein
chemokin
inflammatori
cytokin
ctype
lectin
mbl
ip
et
al
show
mbl
prevent
sarscov
infect
cell
vitro
accord
nonspecif
role
lectin
function
antibodi
respons
ip
et
al
investig
sar
patient
demonstr
significantli
lower
serum
level
mbl
signific
preval
lowsecretor
genet
polymorph
control
similar
conclus
drawn
genet
associ
studi
northern
china
involv
sar
patient
control
subject
reduc
express
function
mbl
attribut
codon
variant
leikin
et
al
show
ydefensin
retrocyclin
inhibit
influenza
viru
entri
cell
crosslink
surfac
glycoprotein
relat
mbl
human
bdefensin
similarli
inhibit
step
preced
viral
entri
leikina
et
al
evid
suggest
adapt
immun
convalesc
patient
confer
last
protect
sarscov
also
determin
outcom
infect
zhang
et
al
convalesc
patient
develop
iggclass
neutral
antibodi
protein
traggiai
et
al
lau
peiri
temperton
et
al
antibodi
prevent
infect
permiss
cell
line
vitro
month
postinfect
titer
neutral
antibodi
sarscov
remain
stabl
traggiai
et
al
chan
et
al
suggest
potenti
last
immun
possibl
develop
effect
vaccin
might
feasibl
identif
sarscov
play
crucial
role
develop
reliabl
diagnost
test
diagnost
test
import
viral
cultur
avail
laboratori
rtpcr
develop
soon
sarscov
identifi
drosten
et
al
ksiazek
et
al
peiri
et
al
time
realtim
quantit
revers
transcriptasepcr
qrtpcr
assay
use
intercal
dye
conjunct
singl
later
dual
taqman
probe
result
signific
increas
sensit
throughput
compar
convent
rtpcr
drosten
et
al
poon
et
al
jiang
et
al
poon
et
al
yip
et
al
network
laboratori
made
avail
variou
primer
protocol
test
http
wwwwhointcsr
sarsprimersenindexhtml
specimen
upper
respiratori
tract
sputum
blood
stool
urin
yield
viral
nucleic
acid
variou
stage
ill
grant
et
al
ng
et
al
tong
et
al
chan
et
al
hung
et
al
ng
et
al
viral
load
data
gener
qrtpcr
later
shown
correl
outcom
chu
et
al
hung
et
al
laboratori
fewer
resourc
concern
shelf
life
diagnost
kit
highli
sensit
gelbas
rtpcr
protocol
target
proteinas
gene
use
test
antibodi
sarscov
howev
plagu
concern
sensit
posit
specif
peiri
ksiazek
drosten
use
indirect
fluoresc
antibodi
ifa
cell
cultur
extractbas
elisa
assay
demonstr
seroconvers
progress
increas
antibodi
titer
sar
drosten
et
al
ksiazek
et
al
peiri
et
al
ifa
specif
labor
intens
addit
theoret
risk
virusinfect
cell
use
microscop
slide
elisa
assay
use
vero
cell
extract
may
yield
falseposit
result
autoantibodi
patient
autoimmun
disord
well
normal
subject
recombin
nbase
elisa
test
woo
et
al
crossreact
hcov
protein
immunoblot
n
could
use
conjunct
assay
identifi
falseposit
result
woo
et
al
recent
chan
et
al
show
sarscov
induc
anamnest
respons
hcov
demand
care
interpret
serolog
find
employ
pepscan
analys
convalesc
patient
sera
vaccineinduc
laboratori
anim
antisera
et
al
identifi
region
protein
uniqu
sarscov
recombin
peptid
region
exploit
overcom
crossreact
recent
develop
elisa
test
correctli
discrimin
sar
convalesc
sera
control
sera
advanc
led
use
pseudotyp
viru
neutral
assay
lieu
sarscov
girogl
et
al
han
et
al
yang
et
al
temperton
et
al
low
sensit
none
rapid
test
exclud
sar
suspect
case
test
differ
type
specimen
collect
differ
time
recommend
peiri
et
al
bermingham
et
al
prolong
infect
respiratori
stool
specimen
demand
care
handl
specimen
microarray
investig
plasma
proteom
approach
diagnosi
develop
issu
molecular
diagnosi
review
elsewher
mahoni
richardson
number
pharmacolog
agent
signific
select
index
cc
divid
ec
sarscov
increas
knowledg
sarscov
biolog
increas
holm
thoma
lai
review
therapeut
experi
sar
epidem
lai
ribavirin
purin
nucleosid
analog
interact
viral
rna
polymeras
well
poorli
character
activ
virus
parker
therapi
hepat
c
viru
ribavirin
thought
act
inhibit
gtp
synthesi
effect
inosin
monophosph
dehydrogenas
therebi
limit
viral
rna
synthesi
enhanc
respons
may
assist
viral
clearanc
thoma
et
al
sarscov
howev
vitro
activ
inconsist
morgenstern
et
al
demonstr
clinic
benefit
uncontrol
seri
patient
van
vonderen
et
al
addit
fact
teratogen
caus
dosedepend
revers
hemolyt
anemia
knowl
et
al
continu
empir
use
sar
recommend
knowl
et
al
van
vonderen
et
al
glycyrrhizin
cinatl
et
al
deriv
hoever
et
al
shown
promis
select
activ
select
activ
index
sarscov
antivir
activ
may
relat
effect
cellular
signal
pathway
transcript
factor
nfkb
upregul
induc
nitrou
oxid
synthas
cinatl
et
al
moreov
effect
lower
plasma
membran
fluiditi
henc
imped
viral
entri
consist
observ
broad
antivir
activ
harada
chloroquin
discov
german
chemist
han
andersag
use
treatment
malaria
amebiasi
hiv
autoimmun
diseas
recogn
activ
sarscov
vitro
select
index
sarscov
vero
cell
cultur
savarino
et
al
keyaert
et
al
vincent
et
al
chloroquin
elev
endosom
ph
interfer
termin
glycosyl
thu
nonspecif
specif
antisarscov
activ
inhibit
sarscov
prevent
assembl
function
replic
complex
bacha
et
al
martina
et
al
conserv
among
coronavirus
suggest
widespectrum
inhibitor
main
proteas
feasibl
yang
et
al
may
use
sever
relat
strain
sarscovlik
virus
li
et
al
homolog
model
reveal
remark
conserv
substratebind
site
among
sarscov
pedv
anand
et
al
howev
one
inhibitor
viral
proteas
show
vitro
activ
concentr
mm
epidem
guangzhou
clinician
observ
hivposit
patient
highli
activ
antiretrovir
therapi
haart
appear
protect
sar
chen
cao
hong
kong
util
lopinavirritonavir
combin
therapi
investig
multicent
retrospect
match
cohort
studi
initi
rescu
therapi
sar
patient
receiv
therapi
initi
treatment
sar
better
outcom
reduc
death
intub
rate
compar
uncontrol
group
lower
rate
use
methylprednisolon
lower
mean
dose
result
similar
subset
patient
report
separ
clinic
trial
agreement
structur
studi
predict
util
lopinavir
ritonavir
niclosamid
promazin
pro
zhang
yap
lopinavir
nelfinavir
also
show
vitro
activ
chu
et
al
yamamoto
et
al
interact
sarscov
host
cell
involv
bind
conform
chang
membran
fusion
possibl
target
therapi
novel
chimer
immunoglobulin
artho
et
al
shown
benefit
treat
similarli
multival
might
efficaci
sarscov
dimitrov
improv
use
residu
civet
li
et
al
similar
mechan
sarscov
mediat
viral
entri
protein
hrderiv
peptid
predict
inhibit
kliger
levanon
later
shown
inhibit
bosch
et
al
sarscov
infect
vero
cell
recombin
protein
contain
shown
potent
inhibitori
activ
entri
hivsar
pseudovirus
cell
ni
et
al
protein
cheaper
produc
synthet
peptid
stabl
cathepsin
l
inhibitor
could
also
studi
entri
inhibitor
monoclon
antibodi
viral
neutral
activ
therapeut
potenti
sar
virus
shown
capabl
prevent
neonat
respiratori
syncyti
viru
infect
johnson
et
al
monoclon
antibodi
protect
ferret
sarscov
infect
ter
meulen
et
al
convalesc
serum
use
sar
patient
though
efficaci
unknown
experiment
infect
mice
possibl
activ
sarscov
infect
latter
wong
et
al
traggiai
et
al
yeh
et
al
improv
bcell
immort
techniqu
employ
cpg
oligonucleotid
cpg
polyclon
bcell
activ
use
epsteinbarr
viru
irradi
allogen
mononuclear
cell
studi
bcell
memori
convalesc
sar
patient
neutral
antibodi
one
stabl
bcell
clone
found
protect
mous
lung
sarscov
challeng
traggiai
et
al
thirtyf
neutral
monoclon
antibodi
isol
studi
eight
recombin
human
singlechain
variabl
region
fragment
scfv
receptorbind
region
protein
identifi
sui
et
al
sui
et
al
one
engin
monoclon
antibodi
show
potent
neutral
sarscov
vitro
anim
studi
ifn
signal
pathway
one
target
sarscov
law
et
al
spiegel
et
al
suggest
may
play
import
role
host
defens
sarscov
unexpectedli
typei
ifn
ab
typeii
inf
g
shown
potent
inhibit
sarscov
infect
replic
zheng
et
al
swedish
scientist
found
natur
ifna
ifnb
potent
vitro
activ
recombin
ifna
chen
et
al
cpg
oligodeoxynucleotid
strongli
stimul
ifna
secret
dendrit
cell
peripher
blood
mononuclear
cell
supernat
fluid
cell
protect
vero
cell
sarscov
infect
macaqu
protect
prophylact
use
pegyl
ifna
postexposur
prophylaxi
sar
ifn
yield
intermedi
result
uncontrol
clinic
experi
ifn
treatment
sar
report
howev
random
doubleblind
control
trial
yet
conduct
effect
vaccin
develop
far
howev
evid
suggest
success
vaccin
may
possibl
molecular
emerg
studi
shown
sarscov
adapt
human
presum
subject
much
evolutionari
pressur
therefor
like
sarscov
make
subsequ
jump
human
anim
cover
vaccin
develop
human
isol
li
et
al
zhi
et
al
niaid
research
engin
attenu
bovinehuman
parainfluenza
viru
express
variou
sarscov
structur
protein
found
structur
protein
e
n
elicit
neutral
antibodi
protect
lung
hamster
sarscov
similar
vaccin
given
nasal
rout
african
green
monkey
cercopithecu
aethiop
shed
viru
upper
respiratori
tract
challeng
sarscov
although
receptorbind
region
sarscov
import
target
neutral
antibodi
region
leu
ala
conserv
across
viral
isol
contain
neutral
antigen
determin
abl
elicit
neutral
antibodi
protect
small
laboratori
mammal
infect
sarscov
pseudoviru
potenti
cytotox
tlymphocyt
ctl
vaccin
candid
cover
individu
major
human
popul
identifi
within
month
public
viru
sequenc
sylvesterhvid
et
al
antibodyenhanc
viral
pathogen
gener
concern
coronavirus
zhang
et
al
sarscov
infect
ferret
get
sever
hepat
first
given
vacciniabas
recombin
sar
vaccin
czub
et
al
recent
niaid
scientist
reveal
pseudoviru
express
partial
human
strain
fig
ref
markedli
resist
neutral
immun
igg
purifi
mice
vaccin
strain
deriv
human
isol
urbani
strain
yang
et
al
antibodi
rais
human
strain
mediat
enhanc
entri
lentivir
vector
express
civet
resist
igg
enhanc
civet
limit
vaccin
mice
human
monoclon
antibodi
creat
immun
repertoir
convalesc
patient
traggiai
et
al
also
exhibit
phenomena
thu
vaccin
human
sarscov
might
enhanc
pathogen
normal
lowpathogen
anim
sarscovlik
viru
anoth
studi
show
sarscov
epitop
employ
vaccin
import
interact
antibodi
conform
epitop
receptorbind
region
shown
respons
antibodyenhanc
viral
pathogen
yang
et
al
delet
portion
truncat
seen
antibodi
induc
promot
enhanc
one
monoclon
antibodi
also
found
mediat
enhanc
consist
studi
shown
crossreact
lung
cell
antigen
lin
et
al
inactiv
sarscov
elicit
neutral
antibodi
takasuka
et
al
tang
et
al
cellular
immun
mice
vaccin
inactiv
sarscov
protect
challeng
intranas
sarscov
spruth
et
al
safeti
concern
inactiv
sarscov
vaccin
inactiv
vaccin
includ
possibl
viral
nucleic
acid
might
remain
infecti
earli
day
inactiv
polioviru
vaccin
katz
offit
anoth
concern
autoantibodi
induc
vero
cell
use
cultiv
sarscov
experiment
vaccin
sarscov
neutral
antibodi
crossreact
abund
human
serum
glycoprotein
asialoorosomucoid
asor
wang
lu
inactiv
sarscov
vaccin
use
alum
adjuv
enter
clinic
trial
china
result
yet
avail
enserink
attenu
sarscov
would
genet
engin
version
could
express
protein
would
transmiss
cell
cell
holm
crossreact
epitop
toxic
viral
protein
imai
et
al
kuba
et
al
would
need
excis
edit
genet
engin
techniqu
construct
manipul
fulllength
sarscov
cdna
yount
et
al
yount
et
al
vector
engin
vaccin
could
includ
weaken
version
human
parainfluenza
viru
call
noninvas
limit
mucosa
known
recombin
unlik
coronavirus
replic
effici
children
engin
might
also
replic
adult
bukreyev
et
al
potenti
yield
vaccin
broad
applic
possibl
vector
adenoviru
use
express
sarscov
gene
use
vaccin
macaqu
monkey
elicit
neutral
antibodi
nspecif
tcell
respons
gao
et
al
highli
attenu
vaccinia
viru
ankara
modifi
express
fulllength
given
intranas
intramuscularli
mice
elicit
crosstransfer
mice
humor
immun
protect
upper
well
lower
respiratori
tract
sarscov
bisht
et
al
viruslik
particl
viral
nucleic
acid
contain
e
protein
produc
taiwan
uk
use
insect
cell
infect
recombin
baculovirus
mortola
roy
might
suitabl
studi
vaccin
dna
vaccin
use
elicit
protect
humor
cellular
immun
sarscov
mous
model
genebas
vaccin
also
test
boost
inactiv
viru
broaden
immun
respons
talaat
stemkehal
combin
nucleocapsid
dna
vaccin
sarscov
n
protein
shown
requir
gener
antibodi
respons
presenc
adjuv
determin
whether
humor
cellular
immun
elicit
azizi
et
al
immun
plasmid
dna
carri
variou
fragment
shown
scientist
hong
kong
univers
elicit
antibodi
mice
fragment
promot
antibodi
isotyp
switch
antibodi
requir
viru
neutral
zeng
et
al
one
studi
experiment
dna
vaccin
sarscov
show
n
alon
suffici
induc
antibodi
ctl
respons
mice
anoth
studi
n
sequenc
link
specifi
calreticulin
enhanc
antigen
present
tcell
efficaci
induc
nspecif
humor
cellular
immun
respons
reduc
viral
titer
mice
challeng
nexpress
vaccinia
viru
mice
immun
plasmid
n
dna
vaccin
abl
elicit
immun
respons
elicit
potent
humor
cellular
immun
respons
respect
wang
et
al
experi
dna
vaccin
human
viral
diseas
limit
variou
anim
model
gurunathan
et
al
although
human
studi
begun
recent
care
design
safeti
could
assur
integr
genom
appear
happen
much
less
often
spontan
mutat
target
deliveri
nucleic
acid
enabl
wider
applic
dna
vaccin
abil
dna
vaccin
elicit
cellular
humor
immun
respons
stabil
simplic
versatil
make
attract
immun
intracellular
pathogen
sarscov
recent
advanc
area
review
taylor
signific
public
health
question
whether
sarscov
return
mani
infecti
diseas
reemerg
recent
histori
fauci
sarscov
made
fleet
reemerg
winter
normil
song
et
al
discoveri
bat
natur
reservoir
appear
like
sarscov
eventu
reemerg
howev
prospect
anoth
larg
outbreak
low
anim
strain
would
adapt
human
becom
epidem
although
imposs
human
isol
sarscov
could
escap
back
wild
human
strain
sarscov
bind
effici
civet
li
et
al
might
also
bind
bat
avid
eas
speci
jump
human
move
area
sarscov
suggest
find
sarscov
rat
identif
serolog
posit
civet
rais
pet
market
farm
shanwei
guangdong
latter
case
seed
anim
farm
bought
variou
market
provinc
tu
et
al
bat
civet
rodent
small
mammal
need
includ
surveil
presenc
sarscov
molecular
emerg
studi
show
adapt
requir
human
sarscov
took
place
within
short
span
earli
epidem
indic
narrow
window
opportun
prevent
reemerg
sar
emerg
viral
infect
miss
opportun
prevent
emerg
sar
manag
limit
damag
condit
lead
reemerg
overdevelop
habitat
destruct
excess
civet
consumpt
poor
hygien
market
farm
etc
poor
market
hygien
manag
major
factor
recent
epidem
major
effort
made
rectifi
situat
culinari
cultur
need
modifi
interest
public
health
civet
remov
menu
guandong
remain
anim
rais
food
must
provid
care
veterinari
servic
wild
anim
left
alon
anthropocentr
modif
natur
environ
lead
seriou
consequ
dobson
care
design
hospit
li
et
al
hous
project
public
place
unseen
microb
mind
view
provid
clean
breath
air
bring
next
quantum
leap
public
health
tong
within
health
care
facil
awar
infect
control
regularli
refresh
convert
health
care
worker
vector
infect
control
lloydsmith
et
al
amidst
excit
progress
vaccin
develop
drug
discoveri
mind
vaccin
seldom
achiev
perfect
immun
drug
resist
expect
howev
best
time
face
emerg
infecti
diseas
even
outbreak
occur
zhong
et
al
kuiken
et
al
vaccin
drug
would
second
line
defens
public
health
measur
first
prevent
viral
adapt
human
receptor
strategi
emerg
viral
diseas
singl
import
translat
molecular
emerg
studi
public
health
manag
last
least
physician
must
serv
sentinel
danger
viru
reilley
et
al
lesson
learn
epidem
reinforc
need
strengthen
surveil
intern
cooper
maintainupgrad
timehonor
infecti
diseas
control
practic
invest
rapid
respons
capabl
paradigm
shift
better
balanc
defens
treatment
preempt
prevent
order
